ACTUATE THERAPEUTICS, INC. business relationships
Companies named in ACTUATE THERAPEUTICS, INC.’s 10-K filed 2026-03-26, and public companies whose annual reports name ACTUATE THERAPEUTICS, INC.. Each link shows the sentence it came from. Scores are Engagemii’s AI visibility scores.
- AEO visibility
- 4.7 / 10
- AI naming
- 4 / 100 Top 3% in its category
- Agent readiness
- 35 / 100
- AI adoption
- 0 / 100
Named in ACTUATE THERAPEUTICS, INC.’s annual report 2
“As part of the collaboration, Lantern Pharma received 13,889 restricted” SEC filing
“Agreement) surrounding GSK-3 inhibitors for Neurodegenerative Disorders were licensed through an Exclusive License Agreement with Equity” SEC filing
Companies whose annual reports name ACTUATE THERAPEUTICS, INC. 1
“May 2021, we entered into a Collaboration Agreement with Actuate Therapeutics, Inc. ("Actuate"), a clinical stage private” SEC filing
Links are read automatically from SEC annual reports (10-K, 20-F, 40-F). In a hand check of random links, about 8 in 10 were real business relationships, so every link carries its source sentence.